You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 128 No. 8, August 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (16)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Prognosis/ Outcomes
 •Neoplasms of Head & Neck
 •Salivary Gland Disorders
 •Alert me on articles by topic

Nodal Metastasis in Major Salivary Gland Cancer

Predictive Factors and Effects on Survival

Neil Bhattacharyya, MD; Marvin P. Fried, MD

Arch Otolaryngol Head Neck Surg. 2002;128:904-908.

Objectives  To determine how regional nodal metastasis affects survival in patients with major salivary gland malignancy and to identify clinical predictors for nodal disease.

Methods  Major salivary gland cancer cases with nodal sampling were identified from the Surveillance, Epidemiology, and End Results cancer database for 1988 through 1998. Kaplan-Meier survival analysis was conducted to compare patients with and without histopathologic evidence of nodal disease. Multivariate logistic regression analysis was used to determine the influence of clinical predictors on the presence of regional nodal disease.

Results  A total of 1268 patients with major salivary gland malignancy and regional node sampling were identified. Mean age at diagnosis was 58.3 years, with a male-female ratio of 1:4. Mean tumor size was 3.0 cm. Overall mean survival time was 83 months (95% confidence interval, 80-87 months). Patients with no evidence of nodal cancer had significantly improved survival over patients with any pathologically positive nodes (mean survival time, 100 months vs 59 months, respectively; P<.001). Patient age, tumor histopathologic type, facial nerve involvement, extraglandular involvement, tumor grade, and tumor size were significant clinical predictors of nodal disease. Facial nerve involvement, tumor grade, and squamous cell carcinoma subtype exhibited the highest increased odds ratios for nodal metastasis.

Conclusions  Nodal disease significantly decreases survival in patients with major salivary gland malignancy. Tumor histopathologic type, facial nerve involvement, extraglandular tumor extension, and tumor grade are the most important predictors of nodal disease.


From the Division of Otolaryngology, Brigham & Women's Hospital, Harvard Medical School, Boston, Mass (Dr Bhattacharyya); and Department of Otolaryngology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY (Dr Fried).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Survival Rates of Sinonasal Squamous Cell Carcinoma With the New AJCC Staging System
Lee et al.
Arch Otolaryngol Head Neck Surg 2007;133:131-134.
ABSTRACT | FULL TEXT  

Surgical Treatment of Cervical Nodal Metastases in Patients With Papillary Thyroid Carcinoma
Bhattacharyya
Arch Otolaryngol Head Neck Surg 2003;129:1101-1104.
ABSTRACT | FULL TEXT  

Survival and Staging Characteristics for Non-Squamous Cell Malignancies of the Maxillary Sinus
Bhattacharyya
Arch Otolaryngol Head Neck Surg 2003;129:334-337.
ABSTRACT | FULL TEXT  

Survival and Prognosis in Hurthle Cell Carcinoma of the Thyroid Gland
Bhattacharyya
Arch Otolaryngol Head Neck Surg 2003;129:207-210.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.